Government ❯ Regulatory Agencies ❯ Federal Trade Commission
Data Privacy Antitrust Enforcement Competition Policy
Regulators warn the merger would unite the only two U.S. clinical trial leaders in TAVR-AR, threatening innovation and raising treatment costs.
